Back to the main directory
Company Analysis / Equity
- PERNOD RICARD - BUY | EUR200(+13%) FY results, slightly above expectations, EBIT up 18% organically by Bryan Garnier
- Kopy Goldfields - Maintaining full year guidance, growth on track by Edison Investment Research
- PERNOD RICARD: Focus on organic sales growth in FY 22 | BUY | EUR200(+12%) by Bryan Garnier
- EKINOPS: Positive read across from ADVA’s acquisition | Conviction BUY Top Picks | EUR10(+30%) by Bryan Garnier
- Ultimovacs - Data continue to impress in Phase I UV1 study by Edison Investment Research
- discoverIE Group - High-margin acquisitions by Edison Investment Research
- PPHE Hotel Group - Checking back in by Edison Investment Research
- Nabaltec - Getting back to pre-pandemic performance by Edison Investment Research
- INTERPARFUMS (NEUTRAL, TP EUR55) | After a strong H1, FY guidance remains almost unchanged: by Bryan Garnier
- Hellenic Petroleum - Expect refining earnings turnaround in H2 by Edison Investment Research
- SPIE - BUY | EUR25(+21%) Motivated to create a pure player champion by Bryan Garnier
- Raven Property Group - Increasing rents and property valuations by Edison Investment Research
- SENSORION - CORPORATE | EUR6(+217%) Strong newsflow ahead, it’s time to jump in by Bryan Garnier
- OSE IMMUNO (CORPORATE, TP EUR17) | Stronger IP ahead of Tedopi’s ESMO presentation by Bryan Garnier
- IBU-tec - Greentech to drive future growth by Edison Investment Research
- Blue Cap - Strong margin improvement in H121 by Edison Investment Research
- THERANEXUS - CORPORATE | EUR20(+131%) BBDF-101 secures IND and moves into clinic by Bryan Garnier
- SENSORION: Cochlear’s collaboration enters clinical stage | CORPORATE | EUR6(+188%) by Bryan Garnier
- The Biotech Growth Trust - Performance setback may provide an opportunity by Edison Investment Research
- POXEL (CORPORATE, TP EUR14.8) | Launch of Twymeeg in Japan by Bryan Garnier
- SOMFY (Conviction BUY, TP EUR180) | “better than expected” would be an understatement by Bryan Garnier
- Severfield - Positive start to FY22 by Edison Investment Research
- Nynomic - Growth accelerates in H121 by Edison Investment Research
- SOMFY - Conviction BUY | EUR190 VS. EUR180 (+10%) Solid long term outlook beyond short term headwinds by Bryan Garnier
- DELIVERY HERO Buy Top Picks, EUR177 vs. EUR167 by Bryan Garnier